Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to main content

Medical Review Institute of America (MRIoA) Sponsors SIIA 2023 Annual National Conference

Medical Review Institute of America(MRIoA)  is once again proud to be a sponsor of SIIA’s National Conference. Please visit us at booth 615 where we can connect through winning conversations about the ever-changing healthcare landscape and how those changes could impact your organization.

Attention to regulatory requirements is the key, and we’re here to unlock the essential insights you need about the impending wave of state regulatory changes. Brace yourself for impactful updates, set to roll out on January 1, 2024. But don’t wait — connect with us now to get the lowdown on the recently effective regulations of 2023. That’s a total of 13 states impacted. Secure your compliance in this transformative era—ask us how!

In addition to helping you stay compliant, MRIoA is excited to announce our new Clinical Solutions Platform™ that takes the data we receive from our Clinical Review Services coupled with MRIoA Insights™, to create a patient-centered approach ensuring patients receive the appropriate care at the right time in the right place.

MRIoA’s data-enabled platform provides invaluable solutions for the healthcare industry:

  • PA Optimization™ – Optimize your prior authorization (PA) program with our cutting-edge platform. This program delivers $1.7M savings annually per 100K lives, or a 7:1 ROI.
  • MyCareChoices™ – Proactive Second Opinion – This innovative service delivers rapid and reliable proactive second opinions and offers conservative treatment options from world-class medical specialists. Your organization can realize $800K in savings for every 100K lives.
  • High-Cost Specialty Drug Reviews™ – Our specialty drug review solution uses evidence-based guidelines for treating medical conditions and offers lower-cost drug alternatives when they are available. One client reduced its drug spend by approximately $265K in a three-month period.
  • Provider Gold Card Services™ – Ease the burden of the medical review process with our new Gold Card service where we streamline the compliance process, reduce your overall costs and increase member/patient care and satisfaction.

We are MRIoA:

  • Providing services to more than 900+ clients across 50% of all third-party administrators, 70% of Blues plans, 8 of the 10 largest health plans and 6 of the largest PBMs
  • Monitoring regulatory requirements across multiple states to ensure our clients meet the compliance standards
  • Delivering technology-enabled review services, increasing patient satisfaction and reducing unnecessary care
  • Providing benchmarking analytics and empowering employees by offering them alternative choices through patient-focused telehealth 2nd opinion services
  • Industry-leading <4 hours TAT on over 81% of qualified reviews while maintaining the quality you expect
  • Over 35+ internal medical directors, 70+ pharmacists, 70+ nurses and 700+ physicians across 150+ specialties
  • Licensure in all 50 states

Stop by our booth 615 on Monday afternoon (4:30 pm to 6:30 pm), October 9th during cocktail hour for our wine bar and a MRIoA specialty keepsake insulated wine tumbler.

Engage with me, Adam Schilling, Vice President of Sales and Team Lead for Strategic Accounts and Jeff Wunderlich, Vice President of Sales for Strategic Accounts, during SIIA National Conference to learn more of what MRIoA can do for your organization and your members. In the meantime, to learn more about MRIoA contact us at www.mrioa.com, 800-654-2422.

About Medical Review Institute of America, LLC, (MRIoA). Founded in 1983, Medical Review Institute of America, LLC (MRIoA) is the top medical review company in the United States. With the largest, most extensive review network, industry-leading turnaround times (TATs), and UR licensing in all states that require it, our professionalism, enthusiasm and collaborative approach are transforming clinical care delivery nationwide. MRIoA is a technology-enabled provider of clinical insights to payers and patients through analytics and evidence-based clinical opinions derived from independent specialty reviews and virtual 2nd opinion solutions that empower better decision-making.

Medical Review Institute of America Media Contact:
Dawn Maloney
MRIoA
dawn.maloney@mrioa.com
801-265-6474